NVO
Novo Nordisk A/S
NVO has slightly lower modeled downside risk, despite its lower overall score.
OSUR
OraSure Technologies, Inc.
OSUR has the edge over NVO overall on the model score.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
OSUR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
OSUR's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
OSUR PE Valuation
OSUR has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
OSUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
OSUR has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over OSUR on earnings quality, reporting a profit while its opponent remains loss making.
OSUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.70 | +$0.10 |
| Q2 2026 | -$0.70 | -$0.03 |
| Q1 2026 | -$1.05 | -$0.63 |
| Q4 2025 | -$0.94 | -$0.68 |
| Q3 2025 | -$0.80 | -633% |
| Q2 2025 | -$0.67 | -286% |
| Q1 2025 | -$0.42 | -240% |
| Q4 2024 | -$0.26 | -136% |
OSUR lost $0.70 per share over the past year, a smaller loss than the year before.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over OSUR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over OSUR on profitability, with a higher operating margin.
OSUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.9M | +14% |
| Q2 2026 | $30.6M | -1.9% |
| Q1 2026 | $27.9M | -6.7% |
| Q4 2025 | $26.8M | -29% |
| Q3 2025 | $27.1M | -32% |
| Q2 2025 | $31.2M | -43% |
| Q1 2025 | $29.9M | -45% |
| Q4 2024 | $37.4M | -51% |
OSUR's revenue is recovering but still below its 2023 peak: $31M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +18 points |
| Q2 2026 | 18% | +76 points |
| Q1 2026 | -83% | -24 points |
| Q4 2025 | -75% | -42 points |
| Q3 2025 | -59% | -44 points |
| Q2 2025 | -58% | -53 points |
| Q1 2025 | -59% | -46 points |
| Q4 2024 | -33% | -38 points |
OSUR's operating margin was −42% last quarter, up 17 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over OSUR on cash generation, producing positive trailing cash flow while its opponent burns cash.
OSUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.5M | -$1.6M |
| Q2 2026 | -$12.3M | -$190K |
| Q1 2026 | -$14.8M | +$5.3M |
| Q4 2025 | -$9.9M | -$9.6M |
| Q3 2025 | -$11M | -188% |
| Q2 2025 | -$12.2M | -295% |
| Q1 2025 | -$20.2M | -491% |
| Q4 2024 | -$347K | -101% |
OSUR has burned cash in most quarters: −$50M over the past year, against −$44M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has 4.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
OSUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -1.2M shares |
| 1 year | -5.5% | -4M shares |
| 3 years | -7.2% | -5.3M shares |
| 5 years | -4.2% | -3M shares |
| Available history | +11% | +6.8M shares |
OSUR has the edge over NVO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $5M |
| Q4 2025 | $5M |
| Q3 2025 | $5M |
| Q2 2025 | $4.1M |
| Q1 2025 | $941,000 |
| Q4 2024 | $15,000 |
OSUR spent $12M buying back its own shares over the past year, up 20% from the year before.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
OSUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -27,857.1x | Net Cash |
| Q2 2024 | -15.0x | Net Cash |
| Q1 2024 | -11.6x | Net Cash |
| Q4 2023 | -5.4x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -3.4x | Net Cash |
| Q1 2023 | -2.8x | Net Cash |
| Q4 2021 | -78.2x | Net Cash |
OSUR has more cash than debt.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
OSUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 42.0 | Neutral |
OSUR's weekly RSI is 49 (neutral) and its Stochastic is 42 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
OSUR PE vs Healthcare Sector
| Metric | OSUR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OSUR has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
OSUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.82 | 5.2% below |
| 20 week MA | $3.84 | 5.7% below |
| 50 week MA | $3.38 | 7.1% above |
| 100 week MA | $3.26 | 11% above |
| 200 week MA | $4.43 | 18% below |
OSUR has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
OSUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.92 | $11.6 | +46% |
| 2021 | $11.6 | $9.25 | -20% |
| 2022 | $9.25 | $4.73 | -49% |
| 2023 | $4.73 | $8.20 | +73% |
| 2024 | $8.20 | $3.62 | -56% |
| 2025 | $3.62 | $2.42 | -33% |
| 2026 YTD | $2.42 | $3.62 | +50% |
OSUR has the edge over NVO on returns for 2026, with the stronger performance.